106 related articles for article (PubMed ID: 3457201)
21. Differentiated HL-60 promyelocytic leukaemia cells produce a factor inducing differentiation.
Djulbegović B; Christmas SE; Moore M
Leuk Res; 1987; 11(3):259-64. PubMed ID: 3470575
[TBL] [Abstract][Full Text] [Related]
22. The novel analog 1,24(S)-dihydroxyvitamin D2 is as equipotent as 1,25-dihydroxyvitamin D3 in growth regulation of cancer cell lines.
Levy Y; Knutson JC; Bishop C; Shany S
Anticancer Res; 1998; 18(3A):1769-75. PubMed ID: 9673403
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of NaF-induced differentiation of HL-60 cells.
Kawase T; Oguro A; Orikasa M; Burns DM
J Bone Miner Res; 1996 Nov; 11(11):1676-87. PubMed ID: 8915775
[TBL] [Abstract][Full Text] [Related]
24. Promotion of HL-60 cell differentiation by 1,25-dihydroxyvitamin D3 regulation of protein kinase C levels and activity.
Pan Q; Granger J; O'Connell TD; Somerman MJ; Simpson RU
Biochem Pharmacol; 1997 Oct; 54(8):909-15. PubMed ID: 9354591
[TBL] [Abstract][Full Text] [Related]
25. Effects of calmodulin antagonists and cytochalasins on proliferation and differentiation of human promyelocytic leukemia cell line HL-60.
Matsui T; Nakao Y; Kobayashi N; Koizumi T; Nakagawa T; Kishihara M; Fujita T
Cancer Res; 1985 Jan; 45(1):311-6. PubMed ID: 3855282
[TBL] [Abstract][Full Text] [Related]
26. 1,25-Dihydroxyvitamin D3 enhances cytosolic free calcium in HL-60 cells.
Barnea E; Levy R; Zimlichman R; Shany S
Exp Hematol; 1990 Dec; 18(11):1147-51. PubMed ID: 2226676
[TBL] [Abstract][Full Text] [Related]
27. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
[TBL] [Abstract][Full Text] [Related]
28. Magnesium deprivation inhibits the expression of differentiation-related phenotypes in human promyelocytic leukemia HL-60 cells.
Okazaki T; Mochizuki T; Tashima M; Sawada H; Uchino H
J Cell Physiol; 1987 Apr; 131(1):50-7. PubMed ID: 3032994
[TBL] [Abstract][Full Text] [Related]
29. Metabolism of vitamin D in human promyelocytic leukemia cells (HL-60) II. Does the differentiation of the cells alter the metabolism?
Imae Y; Shimizu M; Miyaura C; Suda T; Yamada S
Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1989; 23():73-80. PubMed ID: 2488967
[TBL] [Abstract][Full Text] [Related]
30. Differential effects of 1 alpha, 25-dihydroxycholecalciferol and 24R,25-dihydroxycholecalciferol on the proliferation and the differentiated phenotype of rabbit craniofacial chondrocytes in primary culture.
Takano-Yamamoto T; Soma S; Kyung HM; Nakagawa K; Yamashiro T; Sakuda M
J Osaka Univ Dent Sch; 1992 Dec; 32():51-9. PubMed ID: 1341710
[TBL] [Abstract][Full Text] [Related]
31. Reversibility of monocytic differentiation of HL-60 cells by 1alpha,25 dihydroxyvitamin D3.
Tomoyasu S; Fukuchi K; Watanabe K; Ueno H; Hamano Y; Hisatake J; Hino K; Gomi K; Tsuruoka N
Leuk Res; 1997 Mar; 21(3):217-24. PubMed ID: 9111166
[TBL] [Abstract][Full Text] [Related]
32. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
Okuno S; Inaba M; Nishizawa Y; Morii H
Miner Electrolyte Metab; 1995; 21(1-3):211-6. PubMed ID: 7565452
[TBL] [Abstract][Full Text] [Related]
33. 1,25-Dihydroxyvitamin D3-differentiated human promyelocytic leukaemia cells (HL-60) can kill antibody-coated tumour cells (K562).
Espevik T
Scand J Immunol; 1985 Jul; 22(1):105-9. PubMed ID: 3895397
[TBL] [Abstract][Full Text] [Related]
34. Differential effects of 1,25-dihydroxyvitamin D3 on cytosolic calcium in two human cell lines (HL-60 and U-937).
Desai SS; Appel MC; Baran DT
J Bone Miner Res; 1986 Dec; 1(6):497-501. PubMed ID: 3503560
[TBL] [Abstract][Full Text] [Related]
35. Control of proliferating potential of myeloid leukemia cells during long-term treatment with vitamin D3 analogues and other differentiation inducers in combination with antileukemic drugs: in vitro and in vivo studies.
Kasukabe T; Honma Y; Hozumi M; Suda T; Nishii Y
Cancer Res; 1987 Jan; 47(2):567-72. PubMed ID: 3466692
[TBL] [Abstract][Full Text] [Related]
36. Enhancement by dimethyl sulfoxide of 1,25-dihydroxyvitamin D3-induced differentiation in human promyelocytic HL-60 leukemia cells requires dimethyl sulfoxide-induced G0/G1 arrest.
Odani T; Kohroki J; Nakanishi T; Itoh N; Muto N; Tanaka K
Res Commun Mol Pathol Pharmacol; 2000; 108(5-6):381-91. PubMed ID: 11958291
[TBL] [Abstract][Full Text] [Related]
37. Recombinant human GM-CSF significantly enhances the cytostatic activity of cell cycle specific anti-leukaemic drugs in HL-60 human myeloid leukaemia clonogenic cells in a capillary clonogenic micro-assay.
Hassan HT; Veit A; Maurer HR
Anticancer Res; 1991; 11(1):481-5. PubMed ID: 2018385
[TBL] [Abstract][Full Text] [Related]
38. 1Alpha,25-dihydroxyvitamin D3 inhibits programmed cell death in HL-60 cells by activation of sphingosine kinase.
Kleuser B; Cuvillier O; Spiegel S
Cancer Res; 1998 May; 58(9):1817-24. PubMed ID: 9581819
[TBL] [Abstract][Full Text] [Related]
39. Polyamines in 1 alpha, 25-dihydroxycholecalciferol-induced differentiation of human promyelocytic leukemia cells, HL-60.
Inaba M; Otani S; Matsui-Yuasa I; Yukioka K; Nishizawa Y; Ishimura E; Morisada S; Yukioka M; Morisawa S; Morii H
Endocrinology; 1986 May; 118(5):1849-55. PubMed ID: 3084209
[TBL] [Abstract][Full Text] [Related]
40. Resistance to 1,25-dihydroxyvitamin D3 of a deoxycytidine kinase-deficient variant of human leukemia HL60 cells.
Xu HM; Kolla SS; Goldenberg NA; Studzinski GP
Exp Cell Res; 1992 Nov; 203(1):244-50. PubMed ID: 1426045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
